These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20498137)

  • 1. An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells.
    Liu HS; Hsu PY; Lai MD; Chang HY; Ho CL; Cheng HL; Chen HT; Lin YJ; Wu TJ; Tzai TS; Chow NH
    Carcinogenesis; 2010 Aug; 31(8):1456-64. PubMed ID: 20498137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
    Peace BE; Hill KJ; Degen SJ; Waltz SE
    Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR transactivates RON to drive oncogenic crosstalk.
    Franco Nitta C; Green EW; Jhamba ED; Keth JM; Ortiz-Caraveo I; Grattan RM; Schodt DJ; Gibson AC; Rajput A; Lidke KA; Wilson BS; Steinkamp MP; Lidke DS
    Elife; 2021 Nov; 10():. PubMed ID: 34821550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON.
    Chang HY; Liu HS; Lai MD; Tsai YS; Tzai TS; Cheng HL; Chow NH
    Cancer Res; 2014 Aug; 74(16):4549-62. PubMed ID: 24903148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.
    Beauvais DM; Nelson SE; Adams KM; Stueven NA; Jung O; Rapraeger AC
    J Biol Chem; 2022 Jun; 298(6):102029. PubMed ID: 35569509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src.
    Danilkovitch-Miagkova A; Angeloni D; Skeel A; Donley S; Lerman M; Leonard EJ
    J Biol Chem; 2000 May; 275(20):14783-6. PubMed ID: 10747844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation.
    Angeloni D; Danilkovitch-Miagkova A; Miagkov A; Leonard EJ; Lerman MI
    J Biol Chem; 2004 Jan; 279(5):3726-32. PubMed ID: 14597639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus.
    Kim J; Jahng WJ; Di Vizio D; Lee JS; Jhaveri R; Rubin MA; Shisheva A; Freeman MR
    Cancer Res; 2007 Oct; 67(19):9229-37. PubMed ID: 17909029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer.
    Zhao H; Chen MS; Lo YH; Waltz SE; Wang J; Ho PC; Vasiliauskas J; Plattner R; Wang YL; Wang SC
    Oncogene; 2014 Mar; 33(11):1429-37. PubMed ID: 23542172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling ligand-dependent and -independent mechanisms for mitogen-activated protein kinase activation by the murine Ron receptor tyrosine kinase.
    Wei X; Ni S; Correll PH
    J Biol Chem; 2005 Oct; 280(42):35098-107. PubMed ID: 16103119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
    Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
    Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.
    Bardella C; Costa B; Maggiora P; Patane' S; Olivero M; Ranzani GN; De Bortoli M; Comoglio PM; Di Renzo MF
    Cancer Res; 2004 Aug; 64(15):5154-61. PubMed ID: 15289319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break-Inducing Anticancer Drugs.
    Chang HY; Chang TC; Huang WY; Lee CT; Yen CJ; Tsai YS; Tzai TS; Chen SH; Chow NH
    Mol Cancer Ther; 2016 Feb; 15(2):276-86. PubMed ID: 26772202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.
    Hsu PY; Liu HS; Cheng HL; Tzai TS; Guo HR; Ho CL; Chow NH
    J Urol; 2006 Nov; 176(5):2262-7. PubMed ID: 17070309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
    Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
    Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
    Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
    Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between the proto-oncogenes Met and Ron.
    Follenzi A; Bakovic S; Gual P; Stella MC; Longati P; Comoglio PM
    Oncogene; 2000 Jun; 19(27):3041-9. PubMed ID: 10871856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity.
    Klatt A; Zhang Z; Kalantari P; Hankey PA; Gilmour DS; Henderson AJ
    J Immunol; 2008 Feb; 180(3):1670-7. PubMed ID: 18209063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ron kinase transphosphorylation sustains MET oncogene addiction.
    Benvenuti S; Lazzari L; Arnesano A; Li Chiavi G; Gentile A; Comoglio PM
    Cancer Res; 2011 Mar; 71(5):1945-55. PubMed ID: 21212418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.